Ortrexyl is Kalpa Pharmaceuticals methyltrienolone: 250 micrograms per tablet and one hundred tablets in the pack, and that microgram label is the first thing worth noticing. The same molecule is written up as metribolone or R1881 in research work, and in gym usage it is simply oral tren. It is not dosed like anything that sits beside it on a shelf.
Ordering it is the easy part. Running it is a separate question, because this is a methylated oral steroid with a documented reputation as one of the harshest on the liver, and the same references that describe rapid strength gains describe short blocks as the price. Everything below stays with what the source material states and marks the gaps as gaps.
Product Overview
The molecule is a trenbolone relative carrying a methyl group at the seventeenth position. That modification is what lets a tablet survive the digestive route and reach the bloodstream intact, and it is also the origin of the hepatic warning: the 17-alpha-alkylated family is processed by the liver in a way that stresses it, and methyltrienolone is placed at the harder end of that family rather than the gentler one.
It does not aromatise, so there is no estradiol to manage and no water to shed. What it does carry is progestogenic activity, which means tenderness or a lump under the nipple is not automatically an estrogen story and should not be treated as one. The injectable relative in the same line, Trenboxyl Enanthate 200, is a different delivery of a related hormone with its own timeline, and nothing on this page applies to it.
Two data holes are worth naming up front. There is no verified numeric half-life, only a description of an effect measured in hours, so the daily amount is split rather than taken in one go. There is likewise no confirmed human detection window for the substance, even though its sporting status is unambiguous: class S1, prohibited at all times, with metribolone named in the list.
Dosage Protocol
Micrograms, not milligrams. The figures below are the reference range that circulates in the source material, and the top of it is not a target to grow into.
| Beginner | 250 mcg a day, which is exactly one tablet, held for two weeks |
| Intermediate | 250-500 mcg a day for two to three weeks, divided across the day |
| Advanced | Up to 500 mcg a day for three to four weeks at most; sources describe no benefit above that |
| Female | Not recommended. Androgenic potency plus the liver load leaves no defensible protocol |
| Administration | Oral, split into smaller portions through the day because the effect is short |
The arithmetic is unusually simple at this strength, and it is also the safety rail: one tablet is the whole low dose, two tablets are the ceiling, and nothing useful lives above that line. A splitter is not needed, but a calendar is, because a two-week block is easier to overrun than a ten-week one. Dividing the day's total into two or three parts is the practice the short action implies rather than a measured finding.
Suggested Protocols
In practice the tablet is an addition to a plan that already exists, not a plan of its own. It supplies nothing that builds tissue over months, and it is chosen for what it does in days.
Anything else methylated in the same block, for example Haloxyl 10, stacks its own hepatic cost on top of this one. One methylated oral at a time is the rule the sources support.
What to Expect
- Strength moves first. Reports describe a steep jump in the first days, faster than anything a long ester produces, and it fades just as quickly once the block stops.
- Density without water. With no aromatisation the look is harder and flatter rather than fuller, and body weight barely moves.
- Feeling unwell is a signal, not a stage. Appetite loss, lethargy and a general sense of being off are described as early markers of poor tolerance and are treated as reasons to stop.
- The block is short by design. Two weeks is the usual shape, three at the outer edge, and the ceiling is hepatic rather than muscular.
- Blood work is not optional. Liver enzymes are the value that decides whether the block continues, and they are checked during it rather than afterwards.
- Nothing here is a starter compound. The references place it among the most aggressive oral options, which is why it is discussed by experienced users and not recommended first.
Side Effects and Management
Support measures protect the liver; they do not make the compound gentle, and no substance makes a four-week block at the top of the range a reasonable idea.
Post-Cycle Therapy
Because the tablet clears within hours, the recovery phase can begin almost immediately after the last one, which is earlier than for any injectable in the same family.
The recovery drugs pull the axis back on; they do nothing for the liver, which is why the enzyme panel belongs to the block itself and the hormone panel to what comes after it.
Storage and Ordering
Tablets keep in a dry cupboard at room temperature, with the pack closed and the batch code and expiry read on arrival. Given the strength on the label, the meaningful storage question is not temperature but count: a hundred tablets is a lot of two-week blocks, and a pack that outlives its owner's intentions is a pack that tempts a longer run.
Ortrexyl sits in the Kalpa Pharmaceuticals catalogue beside the other methylated orals, Anadroxyl 50 and Haloxyl 10, and beside the recovery shelf it eventually needs, Nolvaxyl 20 and Clomixyl 50. Orders leave in plain packaging and the dispatch options are listed on the product page.
